US BROKER MOVES: AJG double upgraded at Barclays; ORCL upgraded at JPM

UPGRADES Arthur J. Gallagher (AJG) upgraded from Underweight to Overweight at Barclays; PT $262.00 (prev. $247.00) Apyx Medical (APYX) upgraded from Neutral to Buy at BTIG; PT $6.00 CrowdStrike (CRWD) upgraded from Hold to Buy at DZ Bank; PT $490.00 INmune Bio (INMB) upgraded from Neutral to Buy at Lucid Capital Markets; PT $9.00 Intuitive Surgical (ISRG) upgraded from Neutral to Buy at Citi; PT $590.00 NIO (NIO) upgraded from Neutral to Buy at Nomura/Instinet; PT $6.60 (prev. $8.40) Nike (NKE) upgraded from Equalweight to Overweight at Barclays; PT $73.00 (prev. $64.00) Novartis (NVS) upgraded from Hold to Buy at Argus; PT $180.00 Oracle (ORCL) upgraded from Neutral to Overweight at JPMorgan; PT $210.00 J.M. Smucker (SJM) upgraded from Market Perform to Outperform at Bernstein SocGen; PT $145.00 (prev. $121.00) VTEX (VTEX) upgraded from Neutral to Outperform at Bradesco BBI; PT $5.00 Willis Towers Watson (WTW) upgraded from Underweight to Equalweight at Barclays; PT $341.00 (prev. $318.00) DOWNGRADES VICI Properties (VICI) downgraded from Outperform to Neutral at Mizuho; PT $30.00 Yext (YEXT) downgraded from Buy to Neutral at Roth/MKM; PT $6.00 (prev. $9.50) INITIATIONS Compass Diversified (CODI) initiated at Market Perform at Raymond James JOYY Inc. (JOYY) initiated at Buy at UBS; PT $80.00 Ligand Pharmaceuticals (LGND) initiated at Buy at BofA Securities; PT $244.00 Alliant Energy (LNT) initiated at Outperform at RBC Capital; PT $82.00 Ocugen (OCGN) initiated at Outperform at Oppenheimer; PT $10.00